4.3 Limitations
There were a few limitations to the conclusions that could be made from this study. Because subjects were healthy, the pharmacokinetic data collected represented the best case and did not include variability due to patient covariates. As the study was performed in a small number of subjects, conclusions related to safety can only be made for common adverse events, but not rare adverse events.